A reproductive screening test of hawthorn

作者：Yao Mei; Ritchie Helen E^*; Brown Woodman Patricia D

来源：Journal of Ethnopharmacology, 2008, 118(1): 127-132.

DOI：10.1016/j.jep.2008.03.020

• hawthorn
• pregnancy
• rat
• embryo culture
• complementary medicine
• teratology
• developmental toxicology

Aim of study: Hawthorn (Crataegus) has a long history as a medicine. The current clinical use of hawthorn as a heart medicine dates back to the late 19th century. It is well tolerated clinically yet contraindicated in pregnancy.
Materials and methods: To determine the safety of hawthorn to the developing fetus, pregnant rats were dosed daily by gavage using 56 times the human dose of hawthorn on either gestation days (GD) 1-8 or GD 8-15. On GD 20, fetuses were weighed and examined for signs of external, internal or skeletal malformations. Rat fetuses were also explanted on GD 10.5 and cultured with hawthorn extract for 26 h.
Results: Hawthorn did not have an adverse effect on embryonic development in vivo or in vitro.
Conclusions: While the results suggest that hawthorn, taken at the recommended dose would have no adverse effects on embryonic development this may be due to the low bioavailability of some hawthorn constituents when taken orally. Pharmacokinetic studies are required to determine the extent of absorption of hawthorn from the small intestine in healthy adults in order to verify its safety.

• 出版日期2008-6-19